Risk Factors Associated with Stage 3 Renal Failure in Diabetic Patients, Surin Hospital
Main Article Content
Abstract
Background: The leading cause of chronic renal failure in patients is diabetes.
Objective: This study aimed to determine the risk factors of diabetic patients in developing stage III chronic renal failure in Surin Hospital
Methods: Collecting data from January 1st., 2001 to December 31st., 2019. Collecting data back to 2001 and collecting annual blood test data. Once a year from January 1st., 2009, to December 31st., 2021, a retrospective evaluation was conducted to determine which risk factors contributed to the progression of chronic renal failure stage3 and analyzed in subgroups by assessing patients in the first year of diabetes. How much did patients with diabetes in the first year have renal failure or proteinuria.
Results: A total of 626 patients, 179 males, 447 females, received 3027 blood tests. The indicator was patients with stage III chronic renal failure. Kidney function is 30 to 59 units per year, an important factor that causes patients to develop renal failure. Patients over 60 years of age had a 7.67-fold risk of developing chronic renal failure (p-value <0.001). Patients with diabetes longer than 10 years had a 2.03-fold risk. If diabetes is more than 20 years, the risk is 6.2 times. Patients with proteinuria had 3.01 times. Which was statistically significant for all 3 variables (p-value <0.001). When subgroup analysis among patients with diabetes in the first year of diagnosis. It was found that 34.4% of patients with proteinuria from the first year of diabetes diagnosis
Conclusion: Factors associated with stage 3 renal failure in diabetic patients, Surin Hospital is age over 60 years, duration of diabetes and proteinuria.
Article Details

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
World Health Organization. World report on hearing. Geneva: World Health Organization; 2021.
Ogurtsova K, Guariguata L, Barengo NC, Ruiz PL, Sacre JW, Karuranga S, et al. IDF diabetes Atlas: Global estimates of undiagnosed diabetes in adults for 2021. Diabetes Res Clin Pract 2022;183:109118. doi: 10.1016/j.diabres.2021.109118.
No authors in list. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352(9131):837-53. PMID: 9742976
Diabetes Control and Complications Trial Research Group, Nathan DM, Genuth S, Lachin J, Cleary P, Crofford O, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329(14):977-86. doi: 10.1056/NEJM199309303291401.
American Diabetes Association. Standards of medical care in diabetes—2010. Diabetes Care 2010;33 Suppl 1(Suppl 1):S11-61. doi: 10.2337/dc10-S011.
de Boer IH, Khunti K, Sadusky T, Tuttle KR, Neumiller JJ, Rhee CM, Rosas SE, et al. Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO). Diabetes Care 2022;45(12):3075-90. doi: 10.2337/dci22-0027.
Keane WF, Eknoyan G. Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): a position paper of the National Kidney Foundation. Am J Kidney Dis 1999;33(5):1004-10. doi: 10.1016/s0272-6386(99)70442-7.
Ritz E, Stefanski A. Diabetic nephropathy in type II diabetes. Am J Kidney Dis 1996;27(2):167-94. doi: 10.1016/s0272-6386(96)90538-7.
Ritz E, Orth SR. Nephropathy in patients with type 2 diabetes mellitus. N Engl J Med 1999;341(15):1127-33. doi: 10.1056/NEJM199910073411506.
Fabre J, Balant LP, Dayer PG, Fox HM, Vernet AT. The kidney in maturity onset diabetes mellitus: a clinical study of 510 patients. Kidney Int 1982;21(5):730-8. doi: 10.1038/ki.1982.90.
Lea JP, Nicholas SB. Diabetes mellitus and hypertension: key risk factors for kidney disease. J Natl Med Assoc 2002;94(8 Suppl):7S-15S.
azancioğlu R. Risk factors for chronic kidney disease: an update. Kidney Int Suppl (2011) 2013;3(4):368-71. doi: 10.1038/kisup.2013.79.
อัจจิมา กาญจนาภา. โรคไตจากเบาหวานกับวิธีการตรวจ. R&D NEWSLETTER. 2558:22(4);22-4.
จิรวัฒน์ สีตื้อ. ความชุกของโรคไตวายเรื้อรังและปัจจัยเสี่ยงที่สัมพันธ์กับการท างานของไตลดลง ของผู้ป่วยเบาหวานชนิดที่ 2 ในศูนย์สุขภาพชุมชนเขตเมืองร่องซ้อ จังหวัดแพร่.วารสารโรงพยาบาลแพร่ 2562;27(2):1-15.